258 related articles for article (PubMed ID: 24397251)
1. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
Lee JW; Shin HY; Kang HJ; Kim H; Park JD; Park KD; Kim HS; Park SH; Wang KC; Ahn HS
Pediatr Hematol Oncol; 2014 Apr; 31(3):293-302. PubMed ID: 24397251
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
3. Hungarian experience with Langerhans cell histiocytosis in childhood.
Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G;
Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242
[TBL] [Abstract][Full Text] [Related]
4. Langerhans cell histiocytosis in children less than 2 years of age.
Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK
Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of 131 children with multi-system Langerhans cell histiocytosis].
Wu FF; Gao YJ; Pan C; Chen J; Tang JY
Zhonghua Er Ke Za Zhi; 2016 May; 54(5):349-53. PubMed ID: 27143076
[TBL] [Abstract][Full Text] [Related]
6. Langerhans cell histiocytosis: retrospective analysis of 217 cases in a single center.
Yağci B; Varan A; Cağlar M; Söylemezoğlu F; Sungur A; Orhan D; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
Pediatr Hematol Oncol; 2008 Jun; 25(5):399-408. PubMed ID: 18569842
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India.
Narula G; Pradhan ND; Arora B; Banavali SD
Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
9. [Experiences with Langerhans' cell histiocytosis in children in Hungary].
Müller J; Koós R; Garami M; Hauser P; Borgulya G; Schuler D; Benyó G; Magyarosy E; Galántai I; Milei K; Török K; Bárdi E; Hunyadi K; Gábor K; Masáth P; Bodnár L; Kovács G
Magy Onkol; 2004; 48(4):289-95. PubMed ID: 15655573
[TBL] [Abstract][Full Text] [Related]
10. Differentiating skin-limited and multisystem Langerhans cell histiocytosis.
Simko SJ; Garmezy B; Abhyankar H; Lupo PJ; Chakraborty R; Lim KP; Shih A; Hicks MJ; Wright TS; Levy ML; McClain KL; Allen CE
J Pediatr; 2014 Nov; 165(5):990-6. PubMed ID: 25441388
[TBL] [Abstract][Full Text] [Related]
11. Optic glioma in children: a retrospective analysis of 101 cases.
Varan A; Batu A; Cila A; Soylemezoğlu F; Balcı S; Akalan N; Zorlu F; Akyüz C; Kutluk T; Büyükpamukçu M
Am J Clin Oncol; 2013 Jun; 36(3):287-92. PubMed ID: 22547006
[TBL] [Abstract][Full Text] [Related]
12. High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience.
Derenzini E; Stefoni V; Pellegrini C; Gandolfi L; Broccoli A; Casadei B; Quirini F; Argnani L; Tonialini L; Zinzani PL
BMC Cancer; 2015 Nov; 15():879. PubMed ID: 26552668
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cell histiocytosis: 40 years' experience.
Maria Postini A; del Prever AB; Pagano M; Rivetti E; Berger M; Asaftei SD; Barat V; Andreacchio A; Fagioli F
J Pediatr Hematol Oncol; 2012 Jul; 34(5):353-8. PubMed ID: 22627580
[TBL] [Abstract][Full Text] [Related]
14. Langerhans' cell histiocytosis of the temporal bone in children.
Saliba I; Sidani K; El Fata F; Arcand P; Quintal MC; Abela A
Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):775-86. PubMed ID: 18355926
[TBL] [Abstract][Full Text] [Related]
15. Predictors of outcome in children with Langerhans cell histiocytosis.
Jubran RF; Marachelian A; Dorey F; Malogolowkin M
Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
[TBL] [Abstract][Full Text] [Related]
16. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H;
Med Pediatr Oncol; 2002 Dec; 39(6):581-5. PubMed ID: 12376981
[TBL] [Abstract][Full Text] [Related]
17. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
Modest MC; Garcia JJ; Arndt CS; Carlson ML
Laryngoscope; 2016 Aug; 126(8):1899-904. PubMed ID: 26535795
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution.
Braier J; Chantada G; Rosso D; Bernaldez P; Amaral D; Latella A; Balancini B; Masautis A; Goldberg J
Pediatr Hematol Oncol; 1999; 16(5):377-85. PubMed ID: 10505313
[TBL] [Abstract][Full Text] [Related]
19. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
